US suspends imports from oen of Ranbaxy factories
Mumbai: Shares in Indian generic drugs giant Ranbaxy Laboratories crashed as much as 35 pc in early trade on Monday after the US Food and Drug Administration suspended imports from one of its factori
Substandard medicines: SC dismisses plea against Ranbaxy
New Delhi: The Supreme Court on Tuesday dismissed a PIL seeking a probe against Ranbaxy Laboratories Ltd for allegedly manufacturing and selling substandard medicines due to lack of evidence against
European Commission fines 9 pharma firms, including Ranbaxy
New Delhi: The European Commission on Wednesday imposed a fine of 146 million euros on nine pharma companies, including Ranbaxy Laboratories, for delaying market entry of cheaper generic versions of
Apollo warns on Ranbaxy drugs
New Delhi: Apollo Pharmacy on Friday said it has issued a 'cautionary advisory' against drugs made by Ranbaxy Laboratories but it is still selling products manufactured by the Indian drugmaker.
“A ca
Ranbaxy Q1 net profit plunges 90% to Rs 126 cr
Drug major Ranbaxy Laboratories today reported a 89.91 per cent decline in its consolidated net profit at Rs 125.75 crore for the first quarter ended March 31, 2013, mainly on account of absence of contribution from exclusivities.
Indian drug firms okay with US law on enhanced inspection
The Indian generic drug industry is generally receptive to the proposed US law on medicine even though it seeks to enhance US-FDA inspection of the manufacturing facilities globally for a fee.
Indus
Pharma firms sell common drugs at 10 times the cost: MCA
Leading pharma companies including GlaxoSmithkline, Pfizer and Ranbaxy sell commonly used drugs at a rate 10 times the cost of production, a study by the Corporate Affairs Ministry has found.
A st
Ranbaxy hires consultants as part of consent decree with USFDA
Drug major Ranbaxy Laboratories on Friday said it has hired two US-based consultants to advise it on remedial work to be done at its manufacturing units in India as part of a consent decree signed wit
Ranbaxy opens new manufacturing facility in Morocco; eyes $1 billion drug market
Ranbaxy Laboratories has opened a new production facility in Morocco, a move which would help the drug maker access the African nation's USD 1 billion pharma market.
"Ranbaxy Morocco today announced
US seeks injunction against Ranbaxy
In an unprecedented move, the US Justice Department has sought a permanent injunction against Ranbaxy, a move that will require the Indian pharmaceutical major to make fundamental changes to its plant